X linked agammaglobulinaemia with a 'leaky' phenotype.
Alison Jones+6 more
semanticscholar +1 more source
BTK-Inhibition Enhances TLR-7-Mediated Interferon-Alpha Production in pDCs by Blocking the Inhibitory BDCA-2 Pathway. [PDF]
Ceglarek L+5 more
europepmc +1 more source
First Line Therapy in Mantle Cell Lymphoma-The Role of BTKi in the Initial Treatment of Transplant-Eligible and -Ineligible Patients. [PDF]
Silkenstedt E, Dreyling M.
europepmc +1 more source
Australia and New Zealand consensus statement on the cardiovascular management of patients with chronic lymphocytic leukaemia treated with Bruton's tyrosine kinase inhibitors. [PDF]
Anderson MA+9 more
europepmc +1 more source
Drug-Drug Interaction Liabilities with BTK Inhibitor TL-895. [PDF]
Stromatt JC+10 more
europepmc +1 more source
Infectious complications in CLL/SLL patients receiving Bruton's Tyrosine Kinase inhibitors - systematic review and meta-analysis of randomized controlled trials. [PDF]
Buchrits S+8 more
europepmc +1 more source
Bone marrow progenitor cells and vascular endothelium : Studies on the in vivo differentiation capacity and the role of Bmx tyrosine kinase [PDF]
Rajantie, Iiro
core